ProShare Advisors’s Wave Life Sciences WVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $187K | Buy |
28,739
+959
| +3% | +$6.23K | ﹤0.01% | 1741 |
|
|
2025
Q1 | $224K | Sell |
27,780
-5,404
| -16% | -$43.7K | ﹤0.01% | 1614 |
|
|
2024
Q4 | $410K | Sell |
33,184
-10,820
| -25% | -$134K | ﹤0.01% | 1400 |
|
|
2024
Q3 | $361K | Buy |
44,004
+26,594
| +153% | +$218K | ﹤0.01% | 1340 |
|
|
2024
Q2 | $86.9K | Sell |
17,410
-4,354
| -20% | -$21.7K | ﹤0.01% | 1686 |
|
|
2024
Q1 | $134K | Buy |
21,764
+5,648
| +35% | +$34.8K | ﹤0.01% | 1766 |
|
|
2023
Q4 | $81.4K | Buy |
16,116
+1,964
| +14% | +$9.92K | ﹤0.01% | 1807 |
|
|
2023
Q3 | $81.4K | Buy |
14,152
+96
| +0.7% | +$552 | ﹤0.01% | 1665 |
|
|
2023
Q2 | $51.2K | Buy |
+14,056
| New | +$51.2K | ﹤0.01% | 1771 |
|
|
2022
Q2 | – | Sell |
-14,386
| Closed | -$28K | – | 2155 |
|
|
2022
Q1 | $28K | Sell |
14,386
-3,568
| -20% | -$6.95K | ﹤0.01% | 2159 |
|
|
2021
Q4 | $57K | Buy |
17,954
+2,211
| +14% | +$7.02K | ﹤0.01% | 2270 |
|
|
2021
Q3 | $77K | Sell |
15,743
-2,947
| -16% | -$14.4K | ﹤0.01% | 1942 |
|
|
2021
Q2 | $124K | Buy |
18,690
+3,154
| +20% | +$20.9K | ﹤0.01% | 2260 |
|
|
2021
Q1 | $87K | Buy |
15,536
+747
| +5% | +$4.18K | ﹤0.01% | 2181 |
|
|
2020
Q4 | $116K | Buy |
+14,789
| New | +$116K | ﹤0.01% | 1968 |
|
|
2020
Q1 | – | Sell |
-10,468
| Closed | -$84K | – | 1606 |
|
|
2019
Q4 | $84K | Sell |
10,468
-1,377
| -12% | -$11.1K | ﹤0.01% | 1712 |
|
|
2019
Q3 | $243K | Sell |
11,845
-301
| -2% | -$6.18K | ﹤0.01% | 1328 |
|
|
2019
Q2 | $317K | Sell |
12,146
-1,424
| -10% | -$37.2K | ﹤0.01% | 1211 |
|
|
2019
Q1 | $527K | Buy |
13,570
+1,726
| +15% | +$67K | ﹤0.01% | 1000 |
|
|
2018
Q4 | $498K | Buy |
+11,844
| New | +$498K | ﹤0.01% | 953 |
|